Be The First To
To heck with verbs, Seattle Genetics is conjugating antibodies and drugs to fight cancer. The company's technologies use genetically engineered monoclonal antibodies (MAbs, or single source proteins) to trigger cell death in some cancers, but when they can't do it alone, Seattle Genetics pairs them up with drugs using its Antibody-Drug Conjugate (ADC) technology for a one-two punch. Its first product, Adcetris, gained FDA approval in 2011 for treatment of lymphoma in specific patient categories. With partner Millennium Pharmaceuticals, the company is working to expand...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Employees say it's “OK” 13 ratings
54% of the CEO 9 ratings
Clay B. Siegall
President and CEO
Accepted Offer – Reviewed 3 days ago New
Interview Details I had had interviews with other major biotech companies which lasted over 4 hours each, so the ~1 hour interview that I had at Seattle Genetics was wonderfully refreshing. I was offered the position on the spot and just had to wait a couple of weeks for checks and references to make it final. The… – Full Interview
Why do you want to go from working in an academia to industry. – View Answer
Let us know if we're missing any workplace or industry recognition –